A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 4, 2022

Primary Completion Date

September 12, 2024

Study Completion Date

September 12, 2024

Conditions
Advanced Solid TumorsNon-small Cell Lung Cancer
Interventions
BIOLOGICAL

BMS-986442

Specified dose on specified days

BIOLOGICAL

Nivolumab

Specified dose on specified days

DRUG

Docetaxel

Specified dose on specified days

DRUG

Carboplatin

Specified dose on specified days

DRUG

Pemexetred

Specified dose on specified days

DRUG

Paclitaxel

Specified dose on specified days

Trial Locations (32)

2010

Local Institution - 0018, Darlinghurst

2145

Local Institution - 0001, Westmead

3168

Local Institution - 0002, Clayton

4215

Local Institution - 0086, Southport

6150

Local Institution - 0084, Murdoch

10060

Local Institution - 0064, Candiolo

18103

Local Institution - 0046, Allentown

20162

Local Institution - 0065, Milan

28009

Local Institution - 0083, Madrid

28041

Local Institution - 0079, Madrid

28078

Carolina BioOncology Institute, Huntersville

29011

Local Institution - 0082, Málaga

32224

Mayo Clinic in Florida, Jacksonville

32804

Local Institution - 0027, Orlando

41013

Local Institution - 0087, Seville

45219

Local Institution - 0019, Cincinnati

46026

Local Institution - 0081, Valencia

46804

Local Institution - 0029, Fort Wayne

49546

Local Institution - 0005, Grand Rapids

53100

Local Institution - 0077, Siena

55905

Mayo Clinic in Rochester, Minnesota, Rochester

70121

Local Institution - 0022, New Orleans

77030

Local Institution - 0016, Houston

80131

Local Institution - 0062, Napoli

85054

Mayo Clinic in Arizona - Phoenix, Phoenix

85796

Local Institution - 0069, Bydgoszcz

92627

Local Institution - 0096, Costa Mesa

92868-3201

Local Institution - 0075, Orange

07601

Local Institution - 0003, Hackensack

02-781

Local Institution - 0067, Warsaw

80-952

Local Institution - 0073, Gdansk

08035

Local Institution - 0080, Barcelona

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05543629 - A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter